144 related articles for article (PubMed ID: 24616582)
1. Establishment of an orthotopic mouse non-muscle invasive bladder cancer model expressing the mammalian target of rapamycin signaling pathway.
Kim SJ; Seo HK; Seo HH; Lee SJ; Kwon JK; Lee TJ; Chi BH; Chang IH
J Korean Med Sci; 2014 Mar; 29(3):343-50. PubMed ID: 24616582
[TBL] [Abstract][Full Text] [Related]
2. P70S6K and Elf4E dual inhibition is essential to control bladder tumor growth and progression in orthotopic mouse non-muscle invasive bladder tumor model.
Chi BH; Kim SJ; Seo HK; Seo HH; Lee SJ; Kwon JK; Lee TJ; Chang IH
J Korean Med Sci; 2015 Mar; 30(3):308-16. PubMed ID: 25729255
[TBL] [Abstract][Full Text] [Related]
3. Identification of Downstream Genes of the mTOR Pathway that Predict Recurrence and Progression in Non-Muscle Invasive High-Grade Urothelial Carcinoma of the Bladder.
Jin S; Chang IH; Kim JW; Whang YM; Kim HJ; Hong SA; Lee TJ
J Korean Med Sci; 2017 Aug; 32(8):1327-1336. PubMed ID: 28665070
[TBL] [Abstract][Full Text] [Related]
4. A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging.
Hadaschik BA; Black PC; Sea JC; Metwalli AR; Fazli L; Dinney CP; Gleave ME; So AI
BJU Int; 2007 Dec; 100(6):1377-84. PubMed ID: 17850390
[TBL] [Abstract][Full Text] [Related]
5. Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.
Wang W; Chen H; Liu Z; Qu P; Lan J; Chen H; Zou L; Qiu J
Br J Cancer; 2016 Feb; 114(3):305-13. PubMed ID: 26742010
[TBL] [Abstract][Full Text] [Related]
6. Intravesical delivery of rapamycin via folate-modified liposomes dispersed in thermo-reversible hydrogel.
Yoon HY; Chang IH; Goo YT; Kim CH; Kang TH; Kim SY; Lee SJ; Song SH; Whang YM; Choi YW
Int J Nanomedicine; 2019; 14():6249-6268. PubMed ID: 31496684
[TBL] [Abstract][Full Text] [Related]
7. Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics.
Costa C; Pereira S; Lima L; Peixoto A; Fernandes E; Neves D; Neves M; Gaiteiro C; Tavares A; Gil da Costa RM; Cruz R; Amaro T; Oliveira PA; Ferreira JA; Santos LL
PLoS One; 2015; 10(11):e0141253. PubMed ID: 26569621
[TBL] [Abstract][Full Text] [Related]
8. Significance of 4E-binding protein 1 as a therapeutic target for invasive urothelial carcinoma of the bladder.
Nishikawa M; Miyake H; Behnsawy HM; Fujisawa M
Urol Oncol; 2015 Apr; 33(4):166.e9-15. PubMed ID: 25618298
[TBL] [Abstract][Full Text] [Related]
9. An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment.
Huebner D; Rieger C; Bergmann R; Ullrich M; Meister S; Toma M; Wiedemuth R; Temme A; Novotny V; Wirth MP; Bachmann M; Pietzsch J; Fuessel S
BMC Cancer; 2017 Nov; 17(1):790. PubMed ID: 29169339
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a Non-Invasive Semi-Quantitative Bioluminescent Imaging Method for Monitoring of an Orthotopic Esophageal Cancer Mouse Model.
Kuroda S; Kubota T; Aoyama K; Kikuchi S; Tazawa H; Nishizaki M; Kagawa S; Fujiwara T
PLoS One; 2014; 9(12):e114562. PubMed ID: 25493557
[TBL] [Abstract][Full Text] [Related]
11. Mammalian target of rapamycin (mTOR) regulates cellular proliferation and tumor growth in urothelial carcinoma.
Hansel DE; Platt E; Orloff M; Harwalker J; Sethu S; Hicks JL; De Marzo A; Steinle RE; Hsi ED; Theodorescu D; Ching CB; Eng C
Am J Pathol; 2010 Jun; 176(6):3062-72. PubMed ID: 20395440
[TBL] [Abstract][Full Text] [Related]
12. Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer.
Hadaschik BA; Jackson J; Fazli L; Zoubeidi A; Burt HM; Gleave ME; So AI
BJU Int; 2008 Aug; 102(5):610-6. PubMed ID: 18384625
[TBL] [Abstract][Full Text] [Related]
13. Intravesical dual PI3K/mTOR complex 1/2 inhibitor NVP-BEZ235 therapy in an orthotopic bladder cancer model.
Matsushima M; Kikuchi E; Matsumoto K; Hattori S; Takeda T; Kosaka T; Miyajima A; Oya M
Int J Oncol; 2015 Jul; 47(1):377-83. PubMed ID: 25963317
[TBL] [Abstract][Full Text] [Related]
14. Real-time cancer cell tracking by bioluminescence in a preclinical model of human bladder cancer growth and metastasis.
van der Horst G; van Asten JJ; Figdor A; van den Hoogen C; Cheung H; Bevers RF; Pelger RC; van der Pluijm G
Eur Urol; 2011 Aug; 60(2):337-43. PubMed ID: 21616583
[TBL] [Abstract][Full Text] [Related]
15. mTORC1 and mTORC2 play different roles in the functional survival of transplanted adipose-derived stromal cells in hind limb ischemic mice via regulating inflammation in vivo.
Fan W; Cheng K; Qin X; Narsinh KH; Wang S; Hu S; Wang Y; Chen Y; Wu JC; Xiong L; Cao F
Stem Cells; 2013 Jan; 31(1):203-14. PubMed ID: 23081858
[TBL] [Abstract][Full Text] [Related]
16. Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer.
Hadaschik BA; Zhang K; So AI; Fazli L; Jia W; Bell JC; Gleave ME; Rennie PS
Cancer Res; 2008 Jun; 68(12):4506-10. PubMed ID: 18559493
[TBL] [Abstract][Full Text] [Related]
17. Relevance of the mammalian target of rapamycin pathway in the prognosis of patients with high-risk non-muscle invasive bladder cancer.
Fahmy M; Mansure JJ; Brimo F; Yafi FA; Segal R; Althunayan A; Hicks J; Meeker A; Netto G; Kassouf W
Hum Pathol; 2013 Sep; 44(9):1766-72. PubMed ID: 23623586
[TBL] [Abstract][Full Text] [Related]
18. In vivo bioluminescence imaging of tumor hypoxia dynamics of breast cancer brain metastasis in a mouse model.
Saha D; Dunn H; Zhou H; Harada H; Hiraoka M; Mason RP; Zhao D
J Vis Exp; 2011 Oct; (56):. PubMed ID: 21989061
[TBL] [Abstract][Full Text] [Related]
19. Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograft.
Inamoto T; Taniguchi K; Takahara K; Iwatsuki A; Takai T; Komura K; Yoshikawa Y; Uchimoto T; Saito K; Tanda N; Kouno J; Minami K; Uehara H; Hirano H; Nomi H; Kiyama S; Akao Y; Azuma H
Oncotarget; 2015 Aug; 6(25):21628-35. PubMed ID: 26036261
[TBL] [Abstract][Full Text] [Related]
20. Intravesical delivery of rapamycin suppresses tumorigenesis in a mouse model of progressive bladder cancer.
Seager CM; Puzio-Kuter AM; Patel T; Jain S; Cordon-Cardo C; Mc Kiernan J; Abate-Shen C
Cancer Prev Res (Phila); 2009 Dec; 2(12):1008-14. PubMed ID: 19952358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
